Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study

Figures & data

Table 1 Characteristics of Controls and DVT Cases

Variables	DVT Cases (n = 40)	Controls (n =40)	p-value
Gender
Males	21	20	n.s.
Females	19	20
Median Age, y (IQR)	61.5 (44.3–72.0)	58.3 (37.0–66.1)	n.s.
≤ 51.0	17	18	0.115
>52.0	23	12
Median BMI (kg/m^2) (IQR)	27.0 (24.3–38.3)	24.8 (22.4–28.8)	0.327
Normal (< 25)	15	15	n.s
Overweight (25–29.9)	8	8
Obese (≥ 30)	17	17
Anticoagulant therapy (yes/no)	40	0	0.0001

Note: Bold value indicates statistical significant.

Figure 1 Box-plot showing the distribution of microparticle (MP) quantification by controls and DVT cases.

Figure 2 Box-plot showing the distribution of prothrombinase-induced clotting time assay (PiCT) velocity by controls and DVT cases. The asterisks are outliers, and the dots are extreme values. The numbers identify the sample to which the asterisk or dot refers.

Figure 3 Box-plot showing the distribution of phospholipid (PLP) quantification by controls and DVT cases.